Global /Australia /Healthcare /Biotechnology /MEM
chevron_leftBack
Memphasys Ltd. logo

Memphasys Ltd.

MEM
ASX: MEM Delayed
0.0050AUD 0%
0.0035 USD
As of 14 June 2026, Memphasys Ltd. has a market cap of $10.01M USD, ranking #41284 globally and #1326 in Australia. It ranks #3668 in the Healthcare sector, and #716 in the Biotechnology industry.
Global Rank
41284
Country Rank
1326
Sector Rank
3668
Industry Rank
716
Key Stats
Market Cap
$10.01MUSD
14.24M AUD
Enterprise Value
$12.82MUSD
18.2M AUD
Revenue (TTM)
$150.41KUSD
213.98K AUD
EBITDA (TTM)
-$2.43MUSD
-3.45M AUD
Net Income (TTM)
-$3.1MUSD
-4.41M AUD
PS Ratio
66.5
PB Ratio
3.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
David Ali open_in_new
Employees
24
Founded
2006
Website
memphasys.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -9.1% 20% -17% 25% 24%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
MEM
Memphasys Ltd
ISIN: AU000000MEM5
Shares Out.:
2.847B1 Shares Float: 1.892B2
TV:
SA:
YF:
GF:
BA:
MEM
MS:
0.0050 AUD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Memphasys Ltd.

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.

Similar Companies

Industry: Biotechnology (Australia)
Name
Market Cap diff.
PE
CSL
$42.36B
60.27B AUD
423K%
29.3
$3.58B
5.09B AUD
36K%
-
MSB
$2.02B
2.88B AUD
20K%
-
PNV
$490.46M
697.75M AUD
5K%
71.8
$141.64M
1K%
-
IMM
$65.26M
92.84M AUD
552%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
2M%
23.9
GILD
$159.92B
2M%
19.0
ARGX
$47.84B
41.39B EUR
478K%
39.9
$44.84B
68.19T KRW
448K%
35.5
LONN
$42.3B
33.71B CHF
423K%
37.2
068270
$28.11B
42.76T KRW
281K%
43.8
chevron_leftBack